Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2013 (2013), Article ID 340508, 20 pages
http://dx.doi.org/10.1155/2013/340508
Review Article

Biomarkers in Multiple Sclerosis: An Up-to-Date Overview

Immunogenetics Laboratory, 1st Department of Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, 115 28 Athens, Greece

Received 17 October 2012; Revised 13 December 2012; Accepted 18 December 2012

Academic Editor: Jeroen Geurts

Copyright © 2013 Serafeim Katsavos and Maria Anagnostouli. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [25 citations]

The following is the list of published articles that have cited the current article.

  • E D'Amico, F Patti, C Leone, S Lo Fermo, and M Zappia, “Negative prognostic impact of MRI spinal lesions in the early stages of relapsing-remitting multiple sclerosis.,” Multiple sclerosis journal - experimental, translational and clinical, vol. 2, pp. 2055217316631565, . View at Publisher · View at Google Scholar
  • Michael D Ludwig, Anthony P Turel, Ian S Zagon, and Patricia J McLaughlin, “Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis.,” Multiple sclerosis journal - experimental, translational and clinical, vol. 2, pp. 2055217316672242, . View at Publisher · View at Google Scholar
  • Ana L. Moyano, Katarzyna Pituch, Guanan Li, Richard van Breemen, Jan E. Mansson, and Maria I. Givogri, “Levels of plasma sulfatides C18: 0 and C24: 1 correlate with disease status in relapsing-remitting multiple sclerosis,” Journal of Neurochemistry, vol. 127, no. 5, pp. 600–604, 2013. View at Publisher · View at Google Scholar
  • Kavitha Damal, Emily Stoker, and John F Foley, “Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.,” Biologics : targets & therapy, vol. 7, pp. 247–58, 2013. View at Publisher · View at Google Scholar
  • Maria Anagnostouli, Georgios Anagnostoulis, Serafeim Katsavos, Maria Panagiotou, Evangelia Kararizou, and Panagiota Davaki, “HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer,” Journal of The Neurological Sciences, vol. 339, no. 1-2, pp. 26–31, 2014. View at Publisher · View at Google Scholar
  • G. Hassan-Smith, L. Durant, A. Tsentemeidou, L. K. Assi, J. M. Faint, S. Kalra, M. R. Douglas, and S. J. Curnow, “High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis,” Journal of Neuroimmunology, vol. 276, no. 1-2, pp. 175–179, 2014. View at Publisher · View at Google Scholar
  • Ehsan Hejazi, Reza Amani, Naser SharafodinZadeh, and Bahman Cheraghian, “Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects,” Multiple Sclerosis International, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • Christian P. Kamm, Bernard M. Uitdehaag, and Chris H. Polman, “Multiple Sclerosis: Current Knowledge and Future Outlook,” European Neurology, vol. 72, no. 3-4, pp. 132–141, 2014. View at Publisher · View at Google Scholar
  • Brit Fitzner, Michael Hecker, and Uwe Klaus Zettl, “Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients,” Autoimmunity Reviews, 2015. View at Publisher · View at Google Scholar
  • Elba Mauriz, Daniela Vallejo, Maria Jesus Tunon, Jesus Maria Rodriguez-Lopez, Roberto Rodriguez-Perez, Javier Sanz-Gomez, and Maria del Camino Garcia-Fernandez, “Effects of dietary supplementation with lemon verbena extracts on serum inflammatory markers of multiple sclerosis patients,” Nutricion Hospitalaria, vol. 31, no. 2, pp. 764–771, 2015. View at Publisher · View at Google Scholar
  • Mehrdad Farrokhi, Masoud Etemadifar, Maryam Sadat Jafary Alavi, Sayyed Hamid Zarkesh-Esfahani, Mohaddeseh Behjati, Ali Rezaei, and Ali Amani-Beni, “TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls,” Immunological Investigations, vol. 44, no. 6, pp. 590–601, 2015. View at Publisher · View at Google Scholar
  • Maria Anagnostouli, Serafeim Katsavos, Andreas Kyrozis, Maria Gontika, Konstantinos I. Voumvourakis, and Elisabeth Kapaki, “Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course,” Neurological Research, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Tjalf Ziemssen, Raimar Kern, and Katja Thomas, “Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach,” BMC Neurology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Maria Anagnostouli, Serafeim Katsavos, Artemios Artemiadis, Markos Zacharis, Paraskevi Argyrou, Ilia Theotoka, Fotini Christidi, Ioannis Zalonis, and Ioannis Liappas, “Determinants of stigma in a cohort of hellenic patients suffering from multiple sclerosis: a cross-sectional study,” BMC Neurology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Emanuele D’Amico, Aurora Zanghì, and Francesco Patti, “Personalized therapy in multiple sclerosis: state of art and future perspectives,” Expert Review of Precision Medicine and Drug Development, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Domenico Plantone, Floriana De Angelis, Anisha Doshi, and Jeremy Chataway, “Secondary Progressive Multiple Sclerosis: Definition and Measurement.,” CNS drugs, vol. 30, no. 6, pp. 517–26, 2016. View at Publisher · View at Google Scholar
  • Emanuele D'Amico, Alessandra Lugaresi, Giacomo Lus, Carlo Pozzilli, Giancarlo Comi, Paola Cavalla, Gabriella Coniglio, Giancarlo Di Battista, Maria Teresa Ferrò, Franco Granella, Enrico Granieri, Enrico Millefiorini, Gioacchino Tedeschi, Mario Zappia, Maria Trojano, Carmela Leone, Vito Lepore, Francesco Patti, Giusi Graziano, Maria Pia Amato, and Roberto Bergamaschi, “The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study,” PLoS ONE, vol. 11, no. 6, 2016. View at Publisher · View at Google Scholar
  • Ana C Londoño, and Carlos A Mora, “Autologous Bone Marrow Transplantation in Multiple Sclerosis: Biomarker Relevance for Patient Recruitment and Follow up.,” Journal of clinical & cellular immunology, vol. 7, no. 5, 2016. View at Publisher · View at Google Scholar
  • Samiie Pouragahi, Marjan Nassiri-Asl, Mohammad Ali Sahraian, Mehdi Sadeghi, Abdolali Banki, Zahra Zamanzadeh, Mitra Ataei, and Mohammad Hossein Sanati, “Utility of Myelin Basic Protein as an Early Prognostic Biomarker in Multiple Sclerosis,” Iranian Red Crescent Medical Journal, vol. InPress, no. InPress, 2016. View at Publisher · View at Google Scholar
  • Ana C. Londo?o, and Carlos A. Mora, “Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis,” F1000Research, vol. 6, pp. 566, 2017. View at Publisher · View at Google Scholar
  • Ana C. Londoño, and Carlos A. Mora, “Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis,” F1000Research, vol. 6, pp. 566, 2017. View at Publisher · View at Google Scholar
  • Christine T.O. Nguyen, Flora Hui, Jason Charng, Shajan Velaedan, Anna K. van Koeverden, Jeremiah K.H. Lim, Zheng He, Vickie H.Y. Wong, Algis J. Vingrys, Bang V. Bui, and Magnus Ivarsson, “Retinal biomarkers provide “insight” into cortical pharmacology and disease,” Pharmacology & Therapeutics, 2017. View at Publisher · View at Google Scholar
  • Sayed Esmaeil Mousavi, Pouria Heydarpour, Jacques Reis, Masoud Amiri, and Mohammad Ali Sahraian, “Multiple sclerosis and air pollution exposure: mechanisms toward brain autoimmunity,” Medical Hypotheses, 2017. View at Publisher · View at Google Scholar
  • Carolina Alves, Sónia Batista, Otília C. d'Almeida, Lívia Sousa, Luís Cunha, Rui Bernardes, and Miguel Castelo-Branco, “The retinal ganglion cell layer predicts normal-appearing white matter tract integrity in multiple sclerosis: A combined diffusion tensor imaging and optical coherence tomography approach,” Human Brain Mapping, 2018. View at Publisher · View at Google Scholar
  • S. Coe, J. Collett, H. Izadi, D. T. Wade, M. Clegg, J. M. Harrison, E. Buckingham, A. Cavey, G. C. DeLuca, J. Palace, and H. Dawes, “A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS),” Pilot and Feasibility Studies, vol. 4, no. 1, 2018. View at Publisher · View at Google Scholar